ShockWave Medical, Inc.
NASDAQ:SWAV
334.75 (USD) • At close May 30, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 218.805 | 202.979 | 186.02 | 180.165 | 161.066 | 144.026 | 131.33 | 120.746 | 93.631 | 84.183 | 65.155 | 55.908 | 31.9 | 22.716 | 19.59 | 10.286 | 15.197 | 14.312 | 11.333 | 10.012 | 7.269 | 5.062 | 3.6 | 2.279 | 1.322 |
| Cost of Revenue
| 28.207 | 25.316 | 24.513 | 24.493 | 21.066 | 17.502 | 17.874 | 16.73 | 12.89 | 12.663 | 10.949 | 9.934 | 7.892 | 6.471 | 5.277 | 3.592 | 5.651 | 5.553 | 4.401 | 4.133 | 3.072 | 3.304 | 1.973 | 1.179 | 0.794 |
| Gross Profit
| 190.598 | 177.663 | 161.507 | 155.672 | 140 | 126.524 | 113.456 | 104.016 | 80.741 | 71.52 | 54.206 | 45.974 | 24.008 | 16.245 | 14.313 | 6.694 | 9.546 | 8.759 | 6.932 | 5.879 | 4.197 | 1.758 | 1.627 | 1.1 | 0.528 |
| Gross Profit Ratio
| 0.871 | 0.875 | 0.868 | 0.864 | 0.869 | 0.878 | 0.864 | 0.861 | 0.862 | 0.85 | 0.832 | 0.822 | 0.753 | 0.715 | 0.731 | 0.651 | 0.628 | 0.612 | 0.612 | 0.587 | 0.577 | 0.347 | 0.452 | 0.483 | 0.399 |
| Reseach & Development Expenses
| 44.466 | 42.321 | 39.526 | 36.829 | 26.971 | 23.723 | 20.177 | 20.76 | 17.019 | 14.717 | 13.735 | 11.815 | 10.277 | 9.044 | 7.891 | 8.101 | 11.89 | 10.075 | 8.368 | 6.926 | 7.484 | 6.119 | 5.533 | 5.53 | 5.516 |
| General & Administrative Expenses
| 29.233 | 24.879 | 21.451 | 29.731 | 19.204 | 16.941 | 14.434 | 13.165 | 12.389 | 9.63 | 9.265 | 8.626 | 7.226 | 6.631 | 5.61 | 5.398 | 6.224 | 4.45 | 3.437 | 3.245 | 3.001 | 1.842 | 1.369 | 1.392 | 1.376 |
| Selling & Marketing Expenses
| 74.492 | 67.181 | 56.907 | 56.738 | 54.011 | 43.437 | 42.082 | 40.515 | 35.961 | 33.19 | 28.393 | 25.713 | 23.992 | 16.436 | 13.619 | 11.206 | 10.411 | 9.597 | 8.192 | 6.961 | 5.871 | 4.925 | 4.801 | 4.372 | 3.438 |
| SG&A
| 103.725 | 90.76 | 78.358 | 86.469 | 73.215 | 60.378 | 56.516 | 53.68 | 48.35 | 42.82 | 37.658 | 34.339 | 31.218 | 23.067 | 19.229 | 16.604 | 16.635 | 14.047 | 11.629 | 10.206 | 8.872 | 6.767 | 6.17 | 5.764 | 4.814 |
| Other Expenses
| -2.496 | 15.295 | 4.699 | 1.586 | 2.382 | 4.261 | -1.423 | -1.473 | -0.31 | -0.213 | -0.28 | 0.146 | -0.235 | 0.314 | 0.218 | 0.22 | 0.504 | 0.827 | 0.385 | 0.913 | 0.221 | 0.1 | 0.166 | 0.138 | 0.185 |
| Operating Expenses
| 148.191 | 133.081 | 117.884 | 123.298 | 100.186 | 84.101 | 76.693 | 74.44 | 65.369 | 57.537 | 51.393 | 46.154 | 41.495 | 32.111 | 27.12 | 24.705 | 28.525 | 24.122 | 19.997 | 17.132 | 16.356 | 12.886 | 11.703 | 11.294 | 10.33 |
| Operating Income
| 42.407 | 44.582 | 43.623 | 32.374 | 39.814 | 42.423 | 36.763 | 29.576 | 15.372 | 13.983 | 2.813 | -0.18 | -17.487 | -15.866 | -12.807 | -18.011 | -18.979 | -15.363 | -13.065 | -11.253 | -12.159 | -11.128 | -10.076 | -10.194 | -9.802 |
| Operating Income Ratio
| 0.194 | 0.22 | 0.235 | 0.18 | 0.247 | 0.295 | 0.28 | 0.245 | 0.164 | 0.166 | 0.043 | -0.003 | -0.548 | -0.698 | -0.654 | -1.751 | -1.249 | -1.073 | -1.153 | -1.124 | -1.673 | -2.198 | -2.799 | -4.473 | -7.415 |
| Total Other Income Expenses Net
| -1.783 | 10.878 | 3.966 | 1.44 | 0.923 | 2.231 | -1.642 | -3.241 | -0.654 | -0.634 | -0.622 | 0.146 | -5.758 | 0.314 | 0.218 | 0.22 | 0.504 | 0.827 | 0.385 | 0.913 | -0.388 | 0.101 | 0.062 | 0.148 | 0.226 |
| Income Before Tax
| 49.999 | 55.46 | 45.08 | 33.004 | 40.737 | 44.654 | 35.121 | 26.335 | 14.718 | 13.048 | 2.026 | -0.352 | -23.557 | -15.867 | -12.903 | -18.097 | -18.752 | -14.734 | -12.931 | -10.59 | -12.792 | -11.212 | -10.172 | -10.086 | -9.594 |
| Income Before Tax Ratio
| 0.229 | 0.273 | 0.242 | 0.183 | 0.253 | 0.31 | 0.267 | 0.218 | 0.157 | 0.155 | 0.031 | -0.006 | -0.738 | -0.698 | -0.659 | -1.759 | -1.234 | -1.029 | -1.141 | -1.058 | -1.76 | -2.215 | -2.826 | -4.426 | -7.257 |
| Income Tax Expense
| -5.347 | 11.155 | 10.094 | 4.142 | 1.612 | -96.257 | 0.118 | 0.774 | 0.197 | 0.106 | 0.078 | 0.073 | 0.044 | 0.007 | 0.029 | 0.021 | 0.023 | 0.011 | 0.026 | 0.018 | 0.007 | 0.011 | 0.006 | 0.021 | 0.203 |
| Net Income
| 55.346 | 44.305 | 34.986 | 28.862 | 39.125 | 140.911 | 35.003 | 25.561 | 14.521 | 12.942 | 1.948 | -0.425 | -23.601 | -15.874 | -12.932 | -18.118 | -18.775 | -14.745 | -12.957 | -10.608 | -12.799 | -11.223 | -10.178 | -10.107 | -9.594 |
| Net Income Ratio
| 0.253 | 0.218 | 0.188 | 0.16 | 0.243 | 0.978 | 0.267 | 0.212 | 0.155 | 0.154 | 0.03 | -0.008 | -0.74 | -0.699 | -0.66 | -1.761 | -1.235 | -1.03 | -1.143 | -1.06 | -1.761 | -2.217 | -2.827 | -4.435 | -7.257 |
| EPS
| 1.48 | 1.2 | 0.95 | 0.79 | 1.07 | 3.89 | 0.92 | 0.71 | 0.39 | 0.37 | 0.06 | -0.012 | -0.68 | -0.46 | -0.38 | -0.56 | -0.59 | -0.49 | -0.46 | -0.38 | -1.37 | -1.2 | -0.52 | -0.52 | -0.49 |
| EPS Diluted
| 1.44 | 1.16 | 0.92 | 0.76 | 1.03 | 3.71 | 0.92 | 0.68 | 0.39 | 0.34 | 0.05 | -0.012 | -0.68 | -0.46 | -0.38 | -0.56 | -0.59 | -0.49 | -0.46 | -0.38 | -1.37 | -1.2 | -0.52 | -0.52 | -0.49 |
| EBITDA
| 56.051 | 47.657 | 47.589 | 33.814 | 41.373 | 45.623 | 35.437 | 26.979 | 16.735 | 13.349 | 3.672 | 1.228 | -22.119 | -15.552 | -12.589 | -17.791 | -17.68 | -14.536 | -12.68 | -10.34 | -11.938 | -10.794 | -9.727 | -9.902 | -9.488 |
| EBITDA Ratio
| 0.256 | 0.235 | 0.256 | 0.188 | 0.257 | 0.317 | 0.27 | 0.223 | 0.179 | 0.159 | 0.056 | 0.022 | -0.693 | -0.685 | -0.643 | -1.73 | -1.163 | -1.016 | -1.119 | -1.033 | -1.642 | -2.132 | -2.702 | -4.345 | -7.177 |